2Ohta M, Inoue H, Cottieelli MG, et al.The FHIT gene, spanning the chromosome 3p14. 2 fragile site and renal carcinoma- associated t (3 ; 8) breakpoint, is abnormal in digestive tract cancers. Cell,1996, 84: 587-597.
3Chen J, Brevet A, Blanquet S, et al.Control of 5' 5'-dinucleoside triphosphate catabolism by APH1, a saccharomyces cerevisiae analog of human FHIT. J Bacteriol, 1998, 180: 2345-2349.
4Yuan BZ, Keek-Waggoner C, Zimonjic DB, et al. Alterations of the FHIT gene in human hepatocellular carcinoma. Cancer Res, 2000, 60: 1049-1053.
4Vavvas D, Li X, Avruch I, et al. Identification of Norel as a potential Ras effector. J Biol Chem, 1998, 273: 5439-5442.
5Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res, 2001, 61:3877-3881.
6Lee MG, Kim HY, Byun DS, et al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res, 2001, 61 : 6688-6692.
7Dammann R, Takahashi T, Pfeifer GP. The CpG island of the novel tumor suppressors gene RASSF1A is intensely methylated in primary small cell lung carcinoma. Oncogene, 2001, 20:3563-3567.
8Dammann R, Yang G, Pfeifer GP, et al. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res, 2001, 61 : 3105-3109.
9Kuzmin I, Liu L, Dammann R, et al. Inactivation of RAS Domain Family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res, 2003, 63: 1888- 1893.
10Schagdarsurengin U, Wilkens L, Steinemann D, et al. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene, 2003, 22:1866-1871.
